Concord Wealth Partners’s Medpace MEDP Stock Holding History

Concord Wealth Partners’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-14	Closed	-$2K	–	1039
2020 Q4	$2K	Buy	+14	New	+$1.76K	﹤0.01%	546

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Concord Wealth Partners's MEDP Position: Q1 2021 in Review

Concord Wealth Partners sold out of Medpace (MEDP) in Q1 2021, closing a stake of 14 shares — an estimated $2K sold.

Concord Wealth Partners first reported a position in MEDP in Q4 2020 and held it in 1 quarter. The position peaked at $2K in Q4 2020. 319 funds tracked by Wall St. Rank hold MEDP as of Q1 2021.

Concord Wealth Partners reported no remaining Medpace position as of Q1 2021 after selling out during the quarter.
Concord Wealth Partners sold 14 Medpace shares in Q1 2021, an estimated $2K.
Concord Wealth Partners first reported a position in Medpace in Q4 2020 and held it in 1 quarter.
Concord Wealth Partners's Medpace position peaked at $2K in Q4 2020.
319 funds tracked by Wall St. Rank held Medpace as of Q1 2021.

Based on Concord Wealth Partners's 13F filing for Q1 2021, filed 13 May 2021.